붕소

Investigator-led clinical trial of boron neutron capture therapy system for recurrent high-grade meningiomas after radiation therapy: Randomized phase II study.

1. Neuro Oncol. 2026 Apr 1;28(4):994-1004. doi: 10.1093/neuonc/noaf279. Investigator-led clinical trial of boron neutron capture therapy system for recurrent high-grade meningiomas after radiation therapy: Randomized phase II study. Kashiwagi H(1), Wanibuchi M(1)(2), Ikeda N(1), Nonoguchi N(1),

Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma.

2. Blood Cancer J. 2025 Dec 4;16(1):15. doi: 10.1038/s41408-025-01411-9. Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma. Dimopoulos MA(1), Lonial S(2), Chng WJ(3), Iida S(4), Mateos MV(5), Morgan GJ(6), Li C(7), Byrne C(7), Su

Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants.

3. Br J Clin Pharmacol. 2026 Apr;92(4):1087-1097. doi: 10.1002/bcp.70328. Epub 2025 Nov 20. Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants. Gillon JY(1), Delhomme S(1), Launay

Amorolfine hydrochloride cream and 2% crisaborole ointment: a study on their therapeutic benefits for keratotic tinea pedis.

4. J Dermatolog Treat. 2025 Dec;36(1):2555201. doi: 10.1080/09546634.2025.2555201. Epub 2025 Sep 12. Amorolfine hydrochloride cream and 2% crisaborole ointment: a study on their therapeutic benefits for keratotic tinea pedis. Du N(1), Yang J(2), Lv X(1), Wang Y(1), Min W(2). Author information:

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers.

5. Blood Adv. 2025 Nov 11;9(21):5528-5538. doi: 10.1182/bloodadvances.2025016284. Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers. Caballero-Velázquez T(1), Delgado Serrano J(1), López-Corral L(2), Ferra-Coll C(3), García-Calderón CB(1), Valcá

Pharmacokinetics, Bioequivalence, and Safety Studies of Crisaborole Ointment in Healthy Chinese Subjects.

6. Clin Pharmacol Drug Dev. 2025 Aug;14(8):614-620. doi: 10.1002/cpdd.1552. Epub 2025 Jun 9. Pharmacokinetics, Bioequivalence, and Safety Studies of Crisaborole Ointment in Healthy Chinese Subjects. Wang Y(1), Zhao X(2), Wang T(2), Xiong L(1), Liu X(1), Pan J(1), Yin W(1), Zhang C(1), Dong J(1)

Interactive AI Routines for Pain Symptoms and Loneliness in Older Adults.

7. Pain Manag Nurs. 2025 Oct;26(5):530-537. doi: 10.1016/j.pmn.2025.04.003. Epub 2025 May 5. Interactive AI Routines for Pain Symptoms and Loneliness in Older Adults. Shade MY(1), Yan C(2), Jones VK(2), Boron JB(3). Author information: (1)College of Nursing, University of Nebraska Medical Center

Moderate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.

8. PLoS One. 2025 Apr 29;20(4):e0314199. doi: 10.1371/journal.pone.0314199. eCollection 2025. Moderate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial. Wang S(1)(2), Yang J(

Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma.

9. Sci Rep. 2025 Feb 24;15(1):6538. doi: 10.1038/s41598-025-91126-5. Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma. Wang Y(1), Liu YF(1), Jin SW(1), Tao Y(1), Zhang WP(1), Chen JL(2), Ji

Efficacy and Safety of Proactive Therapy with 2% Crisaborole Ointment in Children with Mild-to-Moderate Atopic Dermatitis: A Randomized Controlled Study.

10. Paediatr Drugs. 2025 May;27(3):367-376. doi: 10.1007/s40272-025-00682-w. Epub 2025 Jan 28. Efficacy and Safety of Proactive Therapy with 2% Crisaborole Ointment in Children with Mild-to-Moderate Atopic Dermatitis: A Randomized Controlled Study. Yang H(1), Li P(2), Shu H(3), Qian H(4), Chen J

Combination of sodium pentaborate pentahydrate, curcumin and piperine treatment induces ferroptosis in hepatocellular carcinoma cells by regulating iron homeostasis and ROS activity in vitro.

11. Med Oncol. 2026 Feb 5;43(3):129. doi: 10.1007/s12032-025-03223-0. Combination of sodium pentaborate pentahydrate, curcumin and piperine treatment induces ferroptosis in hepatocellular carcinoma cells by regulating iron homeostasis and ROS activity in vitro. Degirmenci NS(1), Yildirim Z(1), P

Influence of sole and consortia application of micronutrients for biofortification of zinc, iron and boron for improving maize productivity.

12. Sci Rep. 2025 Sep 26;15(1):33250. doi: 10.1038/s41598-025-18968-x. Influence of sole and consortia application of micronutrients for biofortification of zinc, iron and boron for improving maize productivity. Dawar K(1), Shah MW(2), Alotaibi MO(3)(4), Mian IA(2), Muhammad A(5), Ahmad I(6), Sh

Synergistic Effects of Activatable Photodynamic Therapy and Crisaborole for Psoriasis through Senolysis and Immunomodulation.

13. J Med Chem. 2025 Aug 14;68(15):16395-16409. doi: 10.1021/acs.jmedchem.5c01266. Epub 2025 Jul 25. Synergistic Effects of Activatable Photodynamic Therapy and Crisaborole for Psoriasis through Senolysis and Immunomodulation. Yu Y(1), Lv X(1), Chen Z(1), Li X(2), Chen L(1), Chen Y(1), Gu W(1),

Antifungal agent tavaborole as a potential broad-spectrum serine and metallo-β-lactamases inhibitor.

14. EBioMedicine. 2025 Jun;116:105754. doi: 10.1016/j.ebiom.2025.105754. Epub 2025 May 13. Antifungal agent tavaborole as a potential broad-spectrum serine and metallo-β-lactamases inhibitor. Zhang Y(1), Yang S(1), Deng Z(1), Song H(2), Xie N(1), Tian Y(3), Qin S(4), Liu J(4), Guo Y(5), Wang D(

Anti-cancer effect of sodium pentaborate in combination with cisplatin on lung cancer cell lines.

15. Mol Biol Rep. 2024 Nov 29;52(1):28. doi: 10.1007/s11033-024-10119-1. Anti-cancer effect of sodium pentaborate in combination with cisplatin on lung cancer cell lines. Deniz C(1), Gedik T(1), Yüksel B(1), Cebeci E(1), Şahin F(2). Author information: (1)Faculty of Engineering, Department of Ge

Synergistic effects of boron and saponin in mitigating salinity stress to enhance sweet potato growth.

7. Sci Rep. 2024 Jun 6;14(1):12988. doi: 10.1038/s41598-024-63840-z. Synergistic effects of boron and saponin in mitigating salinity stress to enhance sweet potato growth. Younis U(1), Danish S(2), Datta R(3), Al Obaid S(4), Ansari MJ(5). Author information: (1)Botany Department, The Islamia Uni

Ultrasound-assisted facile synthesis of Boron-Heck-coupled sclareol analogues as potential antibacterial agents against Staphylococcus aureus.

4. J Appl Microbiol. 2022 Dec;133(6):3678-3689. doi: 10.1111/jam.15805. Epub 2022 Sep 22. Ultrasound-assisted facile synthesis of Boron-Heck-coupled sclareol analogues as potential antibacterial agents against Staphylococcus aureus. Jameel S(1)(2), Farooq S(2)(3), Gani I(1)(2), Riyaz-Ul-Hassan S

Phenylthiol-BODIPY-based supramolecular metallacycles for synergistic tumor chemo-photodynamic therapy.

22. Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2203994119. doi: 10.1073/pnas.2203994119. Epub 2022 Jul 11. Phenylthiol-BODIPY-based supramolecular metallacycles for synergistic tumor chemo-photodynamic therapy. Lin X(1), Chen F(1), Yu X(2), Wang H(2), Qiu H(1), Li Y(1), Yin S(1), Stang PJ(3

Letter to the Editor: Boron enhances the antiviral activity of the curcumin against SARS-CoV-2.

13. Rom J Morphol Embryol. 2020 Jul-Sep;61(3):967-970. doi: 10.47162/RJME.61.3.39. Letter to the Editor: Boron enhances the antiviral activity of the curcumin against SARS-CoV-2. Scorei IR(1), Biţă A, Mogoşanu GD. Author information: (1)BioBoron Research Institute, S.C. Natural Research S.R.L.,

Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice.

32. Pharmacol Res. 2021 May;167:105537. doi: 10.1016/j.phrs.2021.105537. Epub 2021 Mar 6. Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice. Fogli S(1), Galimberti S(2), Gori V(3), Del Re M(3), Danesi R(3). Author information: (1)Unit of Clini

Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged ≥2 years with mild-to-moderate atopic dermatitis.

4. J Dermatol. 2023 Jul;50(7):847-855. doi: 10.1111/1346-8138.16792. Epub 2023 May 8. Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged ≥2 years with mild-to-moderate atopic dermatitis. Ma L(1), Zhang L(2), Kobayashi M(3), Tao X(4), Qian Q(5), Cheng H(6), Liu S(7)

The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple Myeloma.

7. Adv Ther. 2023 Feb;40(2):705-717. doi: 10.1007/s12325-022-02355-3. Epub 2022 Dec 4. The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple Myeloma. Chen W(1), Liu A(2), Li L(3). A

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups.

9. Am J Clin Dermatol. 2019 Oct;20(5):711-723. doi: 10.1007/s40257-019-00450-w. Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups. Callender VD(1)(2), Alexis AF(3)(4), Stein Gold LF(5), Lebwohl MG(4), Paller A

Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma.

3. Int J Hematol. 2017 Apr;105(4):445-452. doi: 10.1007/s12185-016-2149-1. Epub 2016 Dec 20. Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma. Suzuki K(1), Handa H(2), Chou T(3), Ishizawa K(4), Takubo T(5),

Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study.

45. J Hematol Oncol. 2015 Sep 4;8:103. doi: 10.1186/s13045-015-0198-1. Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study. Gupta N(1), Goh YT(2), Min CK(3), Lee JH(4), Kim K(5), Wong RS(6), Chim CS(7), Hanle

Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis.

40. Antimicrob Agents Chemother. 2026 Feb 4;70(2):e0154625. doi: 10.1128/aac.01546-25. Epub 2026 Jan 6. Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential anal

[Mechanisms and protective strategies for astronaut skin injury in deep space environments].

15. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Aug 28;50(8):1346-1354. doi: 10.11817/j.issn.1672-7347.2025.250443. [Mechanisms and protective strategies for astronaut skin injury in deep space environments]. [Article in Chinese; Abstract available in Chinese from the publisher] Xie Y(1), Zeng J(

The influence of protective coatings on corrosion resistance in orthodontic magnets: A systematic review of in vitro studies.

20. Int Orthod. 2026 Mar;24(1):101080. doi: 10.1016/j.ortho.2025.101080. Epub 2025 Oct 8. The influence of protective coatings on corrosion resistance in orthodontic magnets: A systematic review of in vitro studies. Slaymaker J(1), Rossouw E(2), Michelogiannakis D(2). Author information: (1)Dep

New topical molecular targeted therapies for atopic dermatitis in children: A systematic review and meta-analysis.

34. Pediatr Allergy Immunol. 2025 Jun;36(6):e70122. doi: 10.1111/pai.70122. New topical molecular targeted therapies for atopic dermatitis in children: A systematic review and meta-analysis. Murai H(1)(2), Kawamoto N(3), Arima T(4), Okada Y(5), Takeuchi H(6), Miyamoto M(7), Yamamoto-Hanada K(8),

Unveiling Cellular Responses and Underlying Immune Effects Induced by Boron Neutron Capture Therapy.

2. Int J Radiat Oncol Biol Phys. 2025 Oct 1;123(2):452-469. doi: 10.1016/j.ijrobp.2025.04.026. Epub 2025 Apr 29. Unveiling Cellular Responses and Underlying Immune Effects Induced by Boron Neutron Capture Therapy. Mao H(1), Li J(1), Huang C(1), Li Z(1), Ma X(1), Jiang D(1), Zhang X(1), Wang T(1